ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 118 filers reported holding ANIKA THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,130,061 | -36.6% | 114,335 | -11.6% | 0.00% | -50.0% |
| Q2 2023 | $3,359,291 | -9.5% | 129,303 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $3,713,582 | +10.4% | 129,303 | +13.8% | 0.00% | 0.0% |
| Q4 2022 | $3,364,159 | +24.4% | 113,654 | +0.0% | 0.00% | +100.0% |
| Q3 2022 | $2,704,000 | +57.6% | 113,613 | +47.8% | 0.00% | 0.0% |
| Q2 2022 | $1,716,000 | -13.8% | 76,862 | -3.1% | 0.00% | 0.0% |
| Q1 2022 | $1,991,000 | -14.4% | 79,312 | +22.2% | 0.00% | 0.0% |
| Q4 2021 | $2,325,000 | +15.3% | 64,892 | +36.9% | 0.00% | 0.0% |
| Q3 2021 | $2,017,000 | -1.7% | 47,392 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $2,052,000 | +6.2% | 47,392 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $1,933,000 | +15.4% | 47,392 | +28.1% | 0.00% | 0.0% |
| Q4 2020 | $1,675,000 | +27.9% | 37,000 | -0.1% | 0.00% | 0.0% |
| Q3 2020 | $1,310,000 | -2.6% | 37,021 | +0.1% | 0.00% | 0.0% |
| Q2 2020 | $1,345,000 | – | 37,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 490,331 | $21,928,000 | 10.27% |
| CAPITAL MANAGEMENT CORP /VA | 211,660 | $9,465,000 | 3.66% |
| AMI ASSET MANAGEMENT CORP | 336,791 | $15,061,000 | 1.03% |
| Baltimore-Washington Financial Advisors, Inc. | 68,785 | $3,076,000 | 0.93% |
| Portolan Capital Management | 130,939 | $5,856,000 | 0.78% |
| Kalos Management, Inc. | 19,254 | $861,000 | 0.72% |
| DIKER MANAGEMENT LLC | 32,965 | $1,474,000 | 0.56% |
| THOMPSON SIEGEL & WALMSLEY LLC | 1,526,244 | $68,253,000 | 0.56% |
| NEW AMSTERDAM PARTNERS LLC/NY | 108,260 | $4,841,000 | 0.51% |
| Boston Trust Walden Corp | 493,780 | $22,082,000 | 0.38% |